These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7912649)

  • 1. [Myocardial protection: a look to the future].
    Agati L; Penco M; Dagianti A
    Cardiologia; 1993 Dec; 38(12 Suppl 1):101-9. PubMed ID: 7912649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The protection of myocardial ischemia--reperfusion injury].
    Miura M; Fujiwara Y
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():667-74. PubMed ID: 12735048
    [No Abstract]   [Full Text] [Related]  

  • 3. Postischemic mechanical and vascular dysfunction (myocardial "stunning" and microvascular "stunning") and the effects of calcium-channel blockers on ischemia/reperfusion injury.
    Bolli R; Triana F; Jeroudi MO
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III16-25. PubMed ID: 2691139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers, calcium channel blockers and the sulfhydryl-ACE inhibitors demonstrate protection against free-radical-mediated injury of cardiovascular cells and membranes.
    Weglicki WB; Mak IT; Dickens BF; Kramer JH
    Rev Port Cardiol; 1992 Nov; 11(11):1009-11. PubMed ID: 1363271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of microvascular angina].
    Lanza GA; Cianflone D; Buffon A; Crea F; Maseri A
    Cardiologia; 1993 Dec; 38(12 Suppl 1):169-79. PubMed ID: 7912650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
    Dirksen MT; Laarman GJ; Simoons ML; Duncker DJ
    Cardiovasc Res; 2007 Jun; 74(3):343-55. PubMed ID: 17306241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors.
    Juggi JS; Koenig-Berard E; Van Gilst WH
    Can J Cardiol; 1993 May; 9(4):336-52. PubMed ID: 8513428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ASCOT trial: a closer look.
    Kaplan NM
    J Hypertens; 2006 Feb; 24(2):211-4. PubMed ID: 16508561
    [No Abstract]   [Full Text] [Related]  

  • 9. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury.
    Steffens S; Montecucco F; Mach F
    Thromb Haemost; 2009 Aug; 102(2):240-7. PubMed ID: 19652874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myocardial protection in the patient with angina: bases for a personalized treatment].
    De Servi S; Mariani G
    Cardiologia; 1993 Dec; 38(12 Suppl 1):93-100. PubMed ID: 7912654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertension therapy with beta blocker plus diuretic. "We are at the point of leaving behind an era"].
    Dahlöf B
    MMW Fortschr Med; 2005 Mar; 147(12):8. PubMed ID: 15832781
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
    Chen H; Mohuczy D; Li D; Kimura B; Phillips MI; Mehta P; Mehta JL
    Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-channel antagonists in cardiovascular disease.
    Holdright DR
    Br J Hosp Med; 1997 Jun 4-17; 57(11):552-6. PubMed ID: 9307671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL; Baker WL; White CM
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Silent myocardial ischemia].
    Muranaka A; Tsuchihashi K; Hase M
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():245-8. PubMed ID: 17952998
    [No Abstract]   [Full Text] [Related]  

  • 16. [Protective effects of 3, 6-dimethamidodibenzopyriodinium citrate on myocardial injury induced by ischemia and reperfusion in rats].
    Deng XL; Qiu PL; Liu JT; Chen SY
    Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):367-9. PubMed ID: 8249638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension therapies compared. Are the new nevertheless better than the old?].
    MMW Fortschr Med; 2005 Mar; 147(12):6, 8. PubMed ID: 15832780
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antihypertensive drugs in primary care].
    Gérvas J; Pérez Fernández M
    Med Clin (Barc); 1998 Sep; 111(6):236-7. PubMed ID: 9789233
    [No Abstract]   [Full Text] [Related]  

  • 20. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.